Scleroderma clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

    open to eligible people ages 18-70

    The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus placebo in adult participants with systemic sclerosis. The target population for this study includes patients who meet the 2013…

    at UCLA

  • Platform Clinical Study for Conquering Scleroderma

    Sorry, not currently recruiting here

    The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung capacity in participants with Interstitial Lung…

    at UCLA

Our lead scientists for Scleroderma research studies include .

Last updated: